CHF Solutions Announces Registry for Fluid Overload Conditions in Pediatric Patients

NEXT STORY
TRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA
PREV STORY
Results of Annual General Meeting
Subscribe to PM360
Follow Us

Experts on Call

Get in touch with PM360 Experts On Call

Ads

You May Also Like

Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit

BASEL, Switzerland, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of ...

author_avatar
NASDAQ Market News

ENT and Allergy Associates, LLP’s Adds Strength, Depth and Breadth To its Coming East Brunswick, NJ Office

Tarrytown, NY, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Tarrytown, NY-September 11, 2017:  East Brunswick, ...

author_avatar
NASDAQ Market News

ASLAN Pharmaceuticals to Present Two Posters on Varlitinib at ASCO

SINGAPORE, May 17, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT) (Nasdaq:ASLN), a clinical-stage ...

author_avatar
NASDAQ Market News